Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19

Kara W. Chew; Carlee Moser; Eric S. Daar; David A. Wohl; Jonathan Z. Li; Robert Coombs; Justin Ritz; Mark Giganti; Arzhang Cyrus Javan; Yijia Li; Carlos Malvestutto; Paul Klekotka; Karen Price; Ajay Nirula; William Fischer; Veenu Bala; Ruy M. Ribeiro; Alan S. Perelson; Courtney V. Fletcher; Joseph J. Eron; Judith S. Currier; Michael D. Hughes; Davey M. Smith

bioRxiv (2021) - Comments
doi: 10.1101/2021.12.17.21268009

Kara W. Chew, Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert Coombs, Justin Ritz, Mark Giganti, Arzhang Cyrus Javan, Yijia Li, Carlos Malvestutto, Paul Klekotka, Karen Price, Ajay Nirula, William Fischer, Veenu Bala, Ruy M. Ribeiro, Alan S. Perelson, Courtney V. Fletcher, Joseph J. Eron